Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Equine Interleukin 8 (IL8) Monoclonal Antibody

Cat. No.VD12N187

Product TypeAnimal-targeted Antibodies

Size

Product Overview

BioVenic mouse monoclonal antibody is specific for equine interleukin 8. It is affinity purified by protein A. It can be applied to WB, IHC and IF/ICC assays of equine interleukin 8.

Specifications

Application WB; IHC; IF/ICC
Clonality Monoclonal
Classification Primary Antibody
Clone F13N31
Host Mouse
Target Species Equine
Species Reactivity Equine
Specificity Equine Interleukin 8
Isotype IgG2
Immunogen Recombinant protein of interleukin 8
Purification Protein A Purified
Conjugation Unconjugated
Preservative and Stabilizer 0.05% Proclin 300
Buffer 0.01M Phosphate Buffered Saline, pH 7.4, 50% Glycerol
Physical State Liquid

Target Information

Equine interleukin 8 (IL-8), also known as CXCL8, is a member of the CXC chemokine family produced by macrophages and epithelial cells. It plays a central role in the inflammatory response by recruiting neutrophils to sites of injury or infection. IL-8 is a potent chemoattractant for neutrophils and is involved in various inflammatory processes.

Target Equine Interleukin 8
Target Synonym IL8
Gene ID 100037400
UniProt ID O62812

Shipping and Storage

This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Morini, Maria, et al. "Immunohistochemical Expression of Neurokinin-A and Interleukin-8 in the Bronchial Epithelium of Horses with Severe Equine Asthma Syndrome during Asymptomatic, Exacerbation, and Remission Phase." Animals 11.5 (2021): 1376.
Inquiry Basket